✦ LIBER ✦

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers

✍ Scribed by Osorio, A; Pollán, M; Pita, G; Schmutzler, R K; Versmold, B; Engel, C; Meindl, A; Arnold, N; Preisler-Adams, S; Niederacher, D

Book ID: 109999718
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 79 KB
Volume: 99
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6604624

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A haplotype containing the p53 polymorph

A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers

✍ A. Osorio; B. Martínez-Delgado; M. Pollán; M. Cuadros; M. Urioste; C. Torrentera 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

## Communicated by Dvorah Abeliovich Germline mutations in the BRCA1 and BRCA2 genes confer a high lifetime risk of developing breast and other cancers; however, remarkable differences exist regarding disease manifestation in mutation carriers. It has been suggested that other genetic and/or enviro

The TP53 Arg72Pro and MDM2 309G>T polymo

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

✍ Sinilnikova, O M; Antoniou, A C; Simard, J; Healey, S; Léoné, M; Sinnett, D; Spu 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Promoter methylation patterns of ATM, AT

Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in JewishBRCA1/BRCA2mutation carriers

✍ Tair Kontorovich; Yoram Cohen; Uri Nir; Eitan Friedman 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 276 KB

Smoking and the risk of breast cancer in

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update

✍ Ophira Ginsburg; Parviz Ghadirian; Jan Lubinski; Cezary Cybulski; Henry Lynch; S 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 251 KB

Single-nucleotide polymorphisms in the p

Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent

✍ Ronit I. Yarden; Eitan Friedman; Sally Metsuyanim; Tzvia Olender; Edna Ben-Asher 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

## Abstract Germline mutations in the BRCA1 and BRCA2 genes are associated with a significantly increased lifetime risk for developing breast and/or ovarian cancer. However, incomplete penetrance and substantial variability in age of disease onset among carriers of the same mutation suggests the in

Evaluation of a candidate breast cancer

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

✍ Chen, X; Osorio, A; Milne, R L; Pita, G; Peterlongo, P; Heikkinen, T; Simard, J; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 292 KB